SPY424.31+0.70 0.17%
DIA345.12+0.14 0.04%
IXIC14,069.42+49.09 0.35%

Talaris Therapeutics Shares Fall in Stock Market Debut

05/07/2021 09:49

01:40 PM EDT, 05/07/2021 (MT Newswires) -- Talaris Therapeutics (TALS) shares fell in their stock market debut on Friday after the late-clinical stage cell therapy company priced its initial public offering of about 8.8 million shares at $17 apiece.

The stock was down 1.5% after opening at $17.25.

Price: 16.50, Change: -0.50, Percent Change: -2.94